Ticker Details
Mineralys Therapeutics, Inc.
IPO Date:	February 10, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.55B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 3.29%
Avg Daily Range (30 D):	$0.83 | 3.09%
Avg Daily Range (90 D):	$0.85 | 3.17%

Institutional Daily Volume
Avg Daily Volume:	.56M
Avg Daily Volume (30 D):	1.61M
Avg Daily Volume (90 D):	1.25M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	78
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	1,088
Avg Institutional Trade:	$2.55M
Avg Institutional Trade (30 D):	$3.34M
Avg Institutional Trade (90 D):	$2.91M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.47M
Avg Closing Trade (30 D):	$8.37M
Avg Closing Trade (90 D):	$5.45M
Avg Closing Volume:	171.63K

News

Jun 8, 2026 @ 11:00 AM Mineralys Therapeutics to Present Late-Breaking Da... Source: Na

Jun 3, 2026 @ 10:00 AM Mineralys Therapeutics Announces Repurchase of Roy... Source: Na

May 31, 2026 @ 2:19 PM Velan Capital Drops 140,000 Mineralys Therapeutics... Source: Cory Renauer

May 30, 2026 @ 3:15 PM Mineralys Therapeutics Presents New Data from the ... Source: Mineralys Therapeutics

Nov 7, 2025 @ 11:10 PM Data for Lorundrostat in Chronic Kidney Disease an... Source: Mineralys Therapeutics

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2	$-.47	$-.35
Diluted EPS	$-2	$-.47	$-.35
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-151.78M	$-39.34M	$-32.23M
Operating Income / Loss	$-171.5M	$-45.34M	$-38.28M
Cost of Revenue
Net Cash Flow	$-52.23M	$-60.14M	$-44.68M
PE Ratio